Related references
Note: Only part of the references are listed.Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy
Maria C. Vila et al.
CELL DEATH AND DIFFERENTIATION (2017)
Outside in: The matrix as a modifier of muscular dystrophy
Mattia Quattrocelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Effect of genetic background on the dystrophic phenotype in mdx mice
William D. Coley et al.
HUMAN MOLECULAR GENETICS (2016)
Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy
Cristi L. Galindo et al.
PEDIATRIC RESEARCH (2016)
Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption
Alexis R. Demonbreun et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
OPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophages
Gina M. Many et al.
EXPERIMENTAL PHYSIOLOGY (2016)
Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype
Joana Capote et al.
JOURNAL OF CELL BIOLOGY (2016)
The mdx Mutation in the 129/Sv Background Results in a Milder Phenotype: Transcriptome Comparative Analysis Searching for the Protective Factors
Priscila Clara Calyjur et al.
PLOS ONE (2016)
Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ
Kay-Marie Lamar et al.
PLOS GENETICS (2016)
Genotype-Specific Interaction of Latent TGFβ Binding Protein 4 with TGFβ
Kay-Marie Lamar et al.
PLOS ONE (2016)
Genetic Modifiers of Ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study
Luca Bello et al.
ANNALS OF NEUROLOGY (2015)
Alcohol Inhibits Osteopontin-dependent Transforming Growth Factor-β1 Expression in Human Mesenchymal Stem Cells
Joseph Driver et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle
Mattia Quattrocelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants
Janneke C. van den Bergen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer
C. E. Weber et al.
ONCOGENE (2015)
Myofiber-specific inhibition of TGFβ signaling protects skeletal muscle from injury and dystrophic disease in mice
Federica Accornero et al.
HUMAN MOLECULAR GENETICS (2014)
Excess SMAD signaling contributes to heart and muscle dysfunction in muscular dystrophy
Jeffery A. Goldstein et al.
HUMAN MOLECULAR GENETICS (2014)
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy
Sherry Dadgar et al.
JOURNAL OF CELL BIOLOGY (2014)
Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair
Kayleigh A. Swaggart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Targeting latent TGFβ release in muscular dystrophy
Ermelinda Ceco et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy
Kevin M. Flanigan et al.
ANNALS OF NEUROLOGY (2013)
Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion
Hildegonda P. H. Naber et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Wasting mechanisms in muscular dystrophy
Jonghyun Shin et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
A method for in silico identification of SNAIL/SLUG DNA binding potentials to the E-box sequence using molecular dynamics and evolutionary conserved amino acids
Jeremy W. Prokop et al.
JOURNAL OF MOLECULAR MODELING (2013)
Alterations in Osteopontin Modify Muscle Size in Females in Both Humans and Mice
Eric P. Hoffman et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2013)
Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane
Jaclyn P. Kerr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Age dependent increase in the levels of osteopontin inhibits skeletal muscle regeneration
Preeti Paliwal et al.
AGING-US (2012)
TGFβ signaling: its role in fibrosis formation and myopathies
Elizabeth M. MacDonald et al.
CURRENT OPINION IN RHEUMATOLOGY (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy
Luca Bello et al.
NEUROLOGY (2012)
Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis
Simona Zanotti et al.
HISTOPATHOLOGY (2011)
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy
E. Pegoraro et al.
NEUROLOGY (2011)
Distinct genetic regions modify specific muscle groups in muscular dystrophy
Kayleigh A. Swaggart et al.
PHYSIOLOGICAL GENOMICS (2011)
Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta
Sylvia A. Vetrone et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Latent TGF-β-binding protein 4 modifies muscular dystrophy in mice
Ahlke Heydemann et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
RNA Aptamer Blockade of Osteopontin Inhibits Growth and Metastasis of MDA-MB231 Breast Cancer Cells
Zhiyong Mi et al.
MOLECULAR THERAPY (2009)
Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway
Berta Vidal et al.
GENES & DEVELOPMENT (2008)
Cellular characterization of a novel focal adhesion kinase inhibitor
Jill K. Slack-Davis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Genetic background influences muscular dystrophy
A Heydemann et al.
NEUROMUSCULAR DISORDERS (2005)
Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy
YW Chen et al.
NEUROLOGY (2005)
Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines -: Mechanisms for epithelial mesenchymal transitions
H Peinado et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle
JN Haslett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
GJ Inman et al.
MOLECULAR PHARMACOLOGY (2002)
A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice
JD Porter et al.
HUMAN MOLECULAR GENETICS (2002)
TGF beta and BMP-2 activation of the OPN promoter: Roles of Smad- and Hox-binding elements
TG Hullinger et al.
EXPERIMENTAL CELL RESEARCH (2001)
Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology
YW Chen et al.
JOURNAL OF CELL BIOLOGY (2000)
Osteopontin: a versatile regulator of inflammation and biomineralization
CM Giachelli et al.
MATRIX BIOLOGY (2000)
Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse
AV Tkatchenko et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
Share Paper
